Peanut allergies: FDA approves Palforzia for children
by Press Release from Outbreak News Today on (#4YSRT)
By NewsDesk @infectiousdiseasenews On Friday, the U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Treatment with Palforzia may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued ["]
The post Peanut allergies: FDA approves Palforzia for children appeared first on Outbreak News Today.